Industry News
Biotechnology Industry News
U.K. regulator accepts Humanigen’s COVID drug for speedy review, as analysts spell out reasons to be hopeful for FDA nod
U.K. regulator accepts Humanigen's COVID drug for speedy review, as analysts spell out reasons to be hopeful for FDA nod badams Fri, 07/09/2021 - 07:33
Britain bets on biotech as billions set to boost life sciences sector
Britain bets on biotech as billions set to boost life sciences sector badams Thu, 07/08/2021 - 09:34
Muna raises $73M to go after Alzheimer’s, Parkinson’s and MS
Muna raises $73M to go after Alzheimer's, Parkinson's and MS ntaylor Thu, 07/08/2021 - 09:26
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides’ multiple myeloma drug
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides' multiple myeloma drug ntaylor Thu, 07/08/2021 - 07:55
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides’ multiple myeloma drug
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides' multiple myeloma drug ntaylor Thu, 07/08/2021 - 07:55
Amgen, AstraZeneca’s asthma drug nabs speedy FDA review
Amgen, AstraZeneca's asthma drug nabs speedy FDA review ntaylor Thu, 07/08/2021 - 06:43
Amgen, AstraZeneca’s asthma drug nabs speedy FDA review
Amgen, AstraZeneca's asthma drug nabs speedy FDA review ntaylor Thu, 07/08/2021 - 06:43
Chasing Merck, Arrowhead posts early data on anti-cancer RNAi that could win on safety
Chasing Merck, Arrowhead posts early data on anti-cancer RNAi that could win on safety ntaylor Wed, 07/07/2021 - 08:47
Chasing Merck, Arrowhead posts early data on anti-cancer RNAi that could win on safety
Chasing Merck, Arrowhead posts early data on anti-cancer RNAi that could win on safety ntaylor Wed, 07/07/2021 - 08:47
MIT team employs synthetic biology to create ‘circuits’ that could detect signs of disease
MIT team employs synthetic biology to create 'circuits' that could detect signs of disease arlene.weintraub Wed, 07/07/2021 - 08:31
MIT team employs synthetic biology to create ‘circuits’ that could detect signs of disease
MIT team employs synthetic biology to create 'circuits' that could detect signs of disease arlene.weintraub Wed, 07/07/2021 - 08:31
Improving the response to cancer immunotherapy by reactivating the ‘guardian of the genome’
Improving the response to cancer immunotherapy by reactivating the 'guardian of the genome' aliu Wed, 07/07/2021 - 08:03
Improving the response to cancer immunotherapy by reactivating the ‘guardian of the genome’
Improving the response to cancer immunotherapy by reactivating the 'guardian of the genome' aliu Wed, 07/07/2021 - 08:03
VitriVax bags funding for thermostable, single-dose vaccine R&D
VitriVax bags funding for thermostable, single-dose vaccine R&D ntaylor Wed, 07/07/2021 - 07:58
VitriVax bags funding for thermostable, single-dose vaccine R&D
VitriVax bags funding for thermostable, single-dose vaccine R&D ntaylor Wed, 07/07/2021 - 07:58
New insights into how stem cells shield against RNA viruses could boost COVID-19 R&D
New insights into how stem cells shield against RNA viruses could boost COVID-19 R&D klahucik Tue, 07/06/2021 - 14:47
New insights into how stem cells shield against RNA viruses could boost COVID-19 R&D
New insights into how stem cells shield against RNA viruses could boost COVID-19 R&D klahucik Tue, 07/06/2021 - 14:47
Ocugen climbs on phase 3 COVID vaccine data, hitting back at delta variant
Ocugen climbs on phase 3 COVID vaccine data, hitting back at delta variant badams Tue, 07/06/2021 - 09:15
Ocugen climbs on phase 3 COVID vaccine data, hitting back at delta variant
Ocugen climbs on phase 3 COVID vaccine data, hitting back at delta variant badams Tue, 07/06/2021 - 09:15
Lilly invests in MiNA to fund trials of protein-upregulating RNA
Lilly invests in MiNA to fund trials of protein-upregulating RNA ntaylor Tue, 07/06/2021 - 07:58